首页> 外文期刊>Calcified tissue international. >Polymorphisms in the low-density lipoprotein receptor-related protein 5 (LRP5) gene are associated with peak bone mass in non-sedentary men: results from the Odense androgen study.
【24h】

Polymorphisms in the low-density lipoprotein receptor-related protein 5 (LRP5) gene are associated with peak bone mass in non-sedentary men: results from the Odense androgen study.

机译:低密度脂蛋白受体相关蛋白5(LRP5)基因的多态性与非中枢性男性的骨量峰值相关:来自欧登塞雄激素研究的结果。

获取原文
获取原文并翻译 | 示例
       

摘要

PURPOSE: To investigate the impact of the Ala1330Val (rs3736228, exon 18) and Val667Met (rs4988321, exon 9) polymorphisms of the low-density lipoprotein receptor-related protein 5 (LRP5) gene on peak bone mass in young men. METHODS: The Odense Androgen Study (OAS) is a population-based study comprising 783 Caucasian men aged 20-30 years. Genotyping was performed using real-time polymerase chain reaction (PCR) or fluorescence polarization. Bone mineral density (BMD) measurements were performed using dual-energy X-ray absorptiometry. RESULTS: The CC, CT, and TT genotypes in Ala1330Val were found in 75.6%, 21.8%, and 2.6% of the participants, respectively. Similarly, the GG, GA, and AA genotypes of Val667Met were found in 89.7%, 9.8%, and 0.5%, respectively. For the Ala1330Val polymorphism, no significant differences between the genotypes were found regarding BMD in the overall study population. However, when analysis was restricted to non-sedentary men (n = 589), a significant association between the number of T-alleles and BMD in the spine and whole body were found. Each copy of the T-allele changed the Z-score of the spine by (median and 95% confidence interval) -0.21 [95% CI: -0.40; -0.03] (p < 0.02). Analysis suggested an association between the AA genotype in the Val667Met polymorphism and increased body height and decreased BMD of the femoral neck; however, no significant gene-dose effect of the A-allele could be demonstrated in the whole population. When the analysis was restricted to non-sedentary subjects, however, each number of A-alleles was associated with a change in Z-score of -0.26 [95% CI: -0.51; -0.01] (p = 0.04). No further significant results emerged with haplotype analysis. CONCLUSION: The Ala1330Val and Val667Met polymorphisms in the LRP5 gene are significantly associated with peak bone mass in physically active men.
机译:目的:研究低密度脂蛋白受体相关蛋白5(LRP5)基因的Ala1330Val(rs3736228,外显子18)和Val667Met(rs4988321,外显子9)多态性对年轻人峰值骨量的影响。方法:欧登塞雄激素研究(OAS)是一项基于人群的研究,包括783位20-30岁的白人。使用实时聚合酶链反应(PCR)或荧光偏振进行基因分型。骨矿物质密度(BMD)测量是使用双能X射线吸收仪进行的。结果:Ala1330Val的CC,CT和TT基因型分别占参与者的75.6%,21.8%和2.6%。同样,Val667Met的GG,GA和AA基因型分别为89.7%,9.8%和0.5%。对于Ala1330Val多态性,在整个研究人群中,关于BMD的基因型之间没有发现显着差异。但是,当分析仅限于非中枢性男性(n = 589)时,发现脊椎和全身的T等位基因数量与BMD之间存在显着关联。 T型等位基因的每个副本都将脊柱的Z值改变了(中值和95%置信区间)-0.21 [95%CI:-0.40; -0.03](p <0.02)。分析表明Val667Met多态性的AA基因型与增加的身高和股骨颈的BMD降低之间存在关联。然而,在整个人群中没有显示出A等位基因的显着基因剂量效应。但是,当分析仅限于非必要受试者时,每个A等位基因的Z得分变化都为-0.26 [95%CI:-0.51; -0.01](p = 0.04)。单倍型分析未显示进一步的重要结果。结论:LRP5基因的Ala1330Val和Val667Met多态性与体力活动男性的骨量峰值显着相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号